These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36505387)

  • 21. Culprit vessel only versus multivessel and staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction: a pairwise and network meta-analysis.
    Vlaar PJ; Mahmoud KD; Holmes DR; van Valkenhoef G; Hillege HL; van der Horst IC; Zijlstra F; de Smet BJ
    J Am Coll Cardiol; 2011 Aug; 58(7):692-703. PubMed ID: 21816304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Culprit vessel only versus "one-week" staged percutaneous coronary intervention for multivessel disease in patients presenting with ST-segment elevation myocardial infarction.
    Ma LX; Lu ZH; Wang L; Du X; Ma CS
    J Geriatr Cardiol; 2015 May; 12(3):226-31. PubMed ID: 26089845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Culprit vessel percutaneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial infarction patients with multivessel disease.
    Hannan EL; Samadashvili Z; Walford G; Holmes DR; Jacobs AK; Stamato NJ; Venditti FJ; Sharma S; King SB
    JACC Cardiovasc Interv; 2010 Jan; 3(1):22-31. PubMed ID: 20129564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A risk score based on simple angiographic characteristics to aid in choosing the optimal revascularization strategy for patients with multivessel disease presenting with ST-elevation myocardial infarction.
    Schamroth Pravda N; Witberg G; Zusman O; Landes U; Bental T; Assali A; Vaknin Assa H; Greenberg G; Codner P; Perl L; Kornowski R
    Coron Artery Dis; 2020 Nov; 31(7):597-605. PubMed ID: 32271245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immediate versus staged complete myocardial revascularization in patients with ST-segment elevation myocardial infarction and multivessel disease: A post hoc analysis of the randomized FLOWER-MI trial.
    Tea V; Morelle JF; Gallet R; Cayla G; Lemesle G; Lhermusier T; Dillinger JG; Ducrocq G; Angouvant D; Cottin Y; Chamandi C; le Bras A; Steg PG; Montalescot G; Nelson AC; Simon T; Chatellier G; Danchin N; Puymirat E;
    Arch Cardiovasc Dis; 2022 Oct; 115(10):496-504. PubMed ID: 36096979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-Staged Compared With Multi-Staged PCI in Multivessel NSTEMI Patients: The SMILE Trial.
    Sardella G; Lucisano L; Garbo R; Pennacchi M; Cavallo E; Stio RE; Calcagno S; Ugo F; Boccuzzi G; Fedele F; Mancone M
    J Am Coll Cardiol; 2016 Jan; 67(3):264-72. PubMed ID: 26796390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benefit of a staged in-hospital revascularization strategy in hemodynamically stable patients with ST-segment elevation myocardial infarction and multivessel disease: Analyses by risk stratification.
    Kim MC; Bae S; Ahn Y; Sim DS; Hong YJ; Kim JH; Jeong MH; Kim HS; Chae SC; Cha KS;
    Catheter Cardiovasc Interv; 2021 May; 97(6):1151-1159. PubMed ID: 32569397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.
    Kornowski R; Mehran R; Dangas G; Nikolsky E; Assali A; Claessen BE; Gersh BJ; Wong SC; Witzenbichler B; Guagliumi G; Dudek D; Fahy M; Lansky AJ; Stone GW;
    J Am Coll Cardiol; 2011 Aug; 58(7):704-11. PubMed ID: 21816305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of multivessel versus culprit vessel only percutaneous intervention for patients with multivessel coronary artery disease presenting with acute coronary syndrome.
    Hassanin A; Brener SJ; Lansky AJ; Xu K; Stone GW
    EuroIntervention; 2015 Jul; 11(3):293-300. PubMed ID: 25136882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of the Residual SYNTAX Score on Outcomes of Revascularization in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease.
    Loutfi M; Ayad S; Sobhy M
    Clin Med Insights Cardiol; 2016; 10():29-35. PubMed ID: 26997875
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal Timing of Percutaneous Coronary Intervention for Nonculprit Vessel in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease.
    Kim I; Kim MC; Jeong HC; Park KH; Sim DS; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Seung KB; Chang K; Ahn Y
    Korean Circ J; 2017 Jan; 47(1):36-43. PubMed ID: 28154589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Culprit Vessel-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: A Collaborative Meta-Analysis.
    Kolte D; Sardar P; Khera S; Zeymer U; Thiele H; Hochadel M; Radovanovic D; Erne P; Hambraeus K; James S; Claessen BE; Henriques JPS; Mylotte D; Garot P; Aronow WS; Owan T; Jain D; Panza JA; Frishman WH; Fonarow GC; Bhatt DL; Aronow HD; Abbott JD
    Circ Cardiovasc Interv; 2017 Nov; 10(11):. PubMed ID: 29146672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-Analysis of Culprit-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
    Bangalore S; Toklu B; Stone GW
    Am J Cardiol; 2018 Mar; 121(5):529-536. PubMed ID: 29304995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immediate multivessel intervention versus culprit-vessel intervention only in patients with ST-elevation myocardial infarction and multivessel coronary disease: data from the prospective KAMIR-NIH registry.
    Ahn SG; Lee JW; Kang DR; Kim HS; Go TH; Yu MH; Kim JH; Jung MH; Park JS; Chae SC; Cho MC; Kim CJ; Gwon HC; Kim HS; Seung KB; Cha KS; Chae JK; Joo SJ; Rha SW; Choi DJ; Hur SH; Seong IW; Kim DI; Oh SK; Ahn TH; Hwang JY; Yoon J;
    Coron Artery Dis; 2019 Mar; 30(2):95-102. PubMed ID: 30707685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five-year results of the complete versus culprit vessel percutaneous coronary intervention in multivessel disease using drug-eluting stents II (CORRECT II) study: a prospective, randomised controlled trial.
    Fagel ND; van Nooijen FC; Maarse M; Slagboom T; Herrman JP; van der Schaaf RJ; Amoroso G; Patterson MS; Laarman GJ; Suttorp MJ; Vink MA
    Neth Heart J; 2019 Jun; 27(6):310-320. PubMed ID: 30868547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial.
    Wood DA; Cairns JA; Wang J; Mehran R; Storey RF; Nguyen H; Meeks B; Kunadian V; Tanguay JF; Kim HH; Cheema A; Dehghani P; Natarajan MK; Jolly SS; Amerena J; Keltai M; James S; Hlinomaz O; Niemela K; AlHabib K; Lewis BS; Nguyen M; Sarma J; Dzavik V; Della Siega A; Mehta SR;
    J Am Coll Cardiol; 2019 Dec; 74(22):2713-2723. PubMed ID: 31779786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-Analysis of Randomized Controlled Trials Comparing Multivessel Versus Culprit-Only Revascularization for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention.
    El-Hayek GE; Gershlick AH; Hong MK; Casso Dominguez A; Banning A; Afshar AE; Herzog E; Tamis-Holland JE
    Am J Cardiol; 2015 Jun; 115(11):1481-6. PubMed ID: 25840579
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multivessel Versus Culprit-only Percutaneous Coronary Intervention in ST-segment Elevation Acute Myocardial Infarction: Analysis of an 8-year Registry.
    Galvão Braga C; Cid-Álvarez AB; Redondo Diéguez A; Trillo-Nouche R; Álvarez Álvarez B; López Otero D; Ocaranza Sánchez R; Gestal Romaní S; González Ferreiro R; González-Juanatey JR
    Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):425-432. PubMed ID: 27825718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multivessel disease in patients over 75years old with ST elevated myocardial infarction. Current management strategies and related clinical outcomes in the ESTROFA MI+75 nation-wide registry.
    de La Torre Hernandez JM; Gomez Hospital JA; Baz JA; Brugaletta S; Perez de Prado A; Linares JA; Lopez Palop R; Cid B; Garcia Camarero T; Diego A; Gutierrez H; Fernandez Diaz JA; Sanchis J; Alfonso F; Blanco R; Botas J; Navarro Cuartero J; Moreu J; Bosa F; Vegas JM; Elizaga J; Arrebola AL; Hernandez F; Salvatella N; Monteagudo M; Gomez Jaume A; Carrillo X; Martin Reyes R; Lozano F; Rumoroso JR; Andraka L; Dominguez AJ
    Cardiovasc Revasc Med; 2018; 19(5 Pt B):580-588. PubMed ID: 29306670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multi-vessel versus culprit-vessel and staged percutaneous coronary intervention in STEMI patients with multivessel disease: a meta-analysis of randomized controlled trials.
    Dahal K; Rijal J; Panta R; Lee J; Azrin M; Lootens R
    Cardiovasc Revasc Med; 2014; 15(8):408-13. PubMed ID: 25454258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.